Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms

Status:
Completed

Trial end date:
2018-09-12

Target enrollment:

Participant gender:

The primary objective of this study is to evaluate the long-term safety and tolerability of orally administered telotristat etiprate.

Phase 3

Lexicon Pharmaceuticals